IntelGenx Technologies Corp.
OperatingBiotech · Saint Laurent
Financials
FY2010–FY2023 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 6 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Apr 5, 2024| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Equity | 174,658,096 | — | 100.0% | — |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Bernd Melchers170K (0.1%) Jan 2024 → 282K (0.16%) Feb 2024
- Dr. Horst G. Zerbe5.2M (2.99%) Jan 2024 → 5.3M (3.05%) Feb 2024
Principal holders% as the filing states it, Feb 15, 2024
- Bernd Melchers281,783 shares55.0%of company
- Ingrid Zerbe5,849,709.5 shares3.35%of company
- Dr. Horst G. Zerbe5,324,855.5 shares3.05%of company
- Dwight Gorham9 shares1.19%of company
- Footnotes:1%of company
- Everyone else (not named in filings)36.4%
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
14 peopleShow 5 more peopleShow fewer
Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 85 filings on EDGAR- Form 1-A-WMay 24, 20240001062993-24-011209EDGAR
- Form 10-QMay 15, 20240001062993-24-010322EDGAR
- Form 253G2Apr 12, 20240001062993-24-008327EDGAR
- Form QUALIFApr 11, 20249999999994-24-000051EDGAR
- Form 1-A POSApr 5, 20240001062993-24-008114EDGAR
- Form 10-KMar 21, 20240001062993-24-006905EDGAR
- Form 253G2Feb 20, 20240001062993-24-003608EDGAR
- Form QUALIFFeb 16, 20249999999994-24-000016EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.